• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by WW International Inc.

    5/13/24 4:06:57 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary
    Get the next $WW alert in real time by email
    8-K
    false 0000105319 --12-28 0000105319 2024-05-09 2024-05-09

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): May 9, 2024

     

     

    WW INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Virginia   001-16769   11-6040273
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    675 Avenue of the Americas, 6th Floor, New York, New York   10010
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (212) 589-2700

    Not Applicable

    (Former name or former address, if changed since last report.)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Common Stock, no par value   WW   The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.03.

    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    Effective May 13, 2024, WW International, Inc. (the “Company”) amended and restated its Amended and Restated Articles of Incorporation (as amended, the “Second Amended and Restated Articles of Incorporation”) to delete Section D of Article III thereof to reflect the cancellation of the Company’s previously outstanding Series A Preferred Stock and implement additional immaterial technical and conforming changes. The Second Amended and Restated Articles of Incorporation also reflect the Company’s adoption of a majority voting standard in uncontested elections of directors in place of the previous plurality voting standard, as approved by the Company’s shareholders at the Company’s 2024 annual meeting (the “2024 Annual Meeting”). The Second Amended and Restated Articles of Incorporation retain the plurality voting standard in contested elections of directors.

    Effective May 13, 2024, the Company also amended and restated its Amended and Restated Bylaws (as amended, the “Amended and Restated Bylaws”) to update and expand certain procedural and informational requirements for shareholder nominations for election of directors or proposals of business at the Company’s shareholder meetings pursuant to the Company’s “advance notice” provisions, including updates to reflect the adoption of “universal proxy” rules as set forth in Rule 14a-19 under the Securities and Exchange Act of 1934, as amended. The Amended and Restated Bylaws also delete certain obsolete provisions relating to the equity ownership of the Company’s former controlling shareholder and implement additional immaterial technical and conforming changes.

    The foregoing summary and description of the Second Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the full texts of such documents, copies of which are attached hereto as Exhibits 3.1 and 3.2, respectively, and incorporated herein by reference. In addition, marked copies of the Second Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws showing all changes from the respective prior versions are attached hereto as Exhibits 3.3 and 3.4, respectively.

     

    Item 5.07.

    Submission of Matters to a Vote of Security Holders.

    The Company held the 2024 Annual Meeting on May 9, 2024. At this meeting, the Company’s shareholders (1) elected the persons listed below to serve as Class II directors for a term of three years expiring at the Company’s 2027 annual meeting of shareholders (the “2027 Annual Meeting”) and until their successors have been duly elected and qualified or until the earlier of their resignation, removal, retirement, disqualification or death; (2) elected the persons listed below to serve as Class I directors for a term of two years expiring at the Company’s 2026 annual meeting of shareholders (the “2026 Annual Meeting”) and until their successors have been duly elected and qualified or until the earlier of their resignation, removal, retirement, disqualification or death; (3) ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2024; (4) approved the amendment to the Company’s Amended and Restated Articles of Incorporation to adopt a majority voting standard in uncontested elections of directors; (5) did not approve the amendment to the Company’s Amended and Restated Articles of Incorporation to delete various provisions related to the Company’s former controlling shareholder that are no longer applicable; and (6) approved, on an advisory basis, the Company’s named executive officer compensation. Set forth below are the voting results for these proposals.

     

      1.

    Election of two Class II directors for a term of three years expiring at the 2027 Annual Meeting and until their successors have been duly elected and qualified or until the earlier of their resignation, removal, retirement, disqualification or death:

     

    Nominee Name

     

    Votes For

     

    Votes Withheld

     

    Broker Non-Votes

    Denis F. Kelly

      28,489,452   837,275   22,868,371

    Julie Rice

      27,951,447   1,375,280   22,868,371

     

      2.

    Election of two Class I directors for a term of two years expiring at the 2026 Annual Meeting and until their successors have been duly elected and qualified or until the earlier of their resignation, removal, retirement, disqualification or death:

     

    Nominee Name

     

    Votes For

     

    Votes Withheld

     

    Broker Non-Votes

    Tara Comonte

      28,724,917   601,810   22,868,371

    William H. Shrank, M.D.

      28,720,705   606,022   22,868,371

     

    2


      3.

    Ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2024:

     

    Votes For

     

    Votes Against

     

    Abstentions

     

    Broker Non-Votes

    50,536,629

      1,411,620   246,849   N/A

     

      4.

    Approval of the amendment to the Company’s Amended and Restated Articles of Incorporation to adopt a majority voting standard in uncontested elections of directors:

     

    Votes For

     

    Votes Against

     

    Abstentions

     

    Broker Non-Votes

    28,742,296

      455,758   128,673   22,868,371

     

      5.

    Approval of the amendment to the Company’s Amended and Restated Articles of Incorporation to delete various provisions related to the Company’s former controlling shareholder that are no longer applicable:

     

    Votes For

     

    Votes Against

     

    Abstentions

     

    Broker Non-Votes

    28,937,761

      315,871   73,095   22,868,371

     

      6.

    Advisory vote to approve the Company’s named executive officer compensation:

     

    Votes For

     

    Votes Against

     

    Abstentions

     

    Broker Non-Votes

    16,276,923

      12,917,758   132,046   22,868,371

     

    Item 9.01.

    Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit

      

    Description

    Exhibit 3.1    Second Amended and Restated Articles of Incorporation of WW International, Inc. (effective May 13, 2024).
    Exhibit 3.2    Amended and Restated Bylaws of WW International, Inc. (effective May 13, 2024).
    Exhibit 3.3    Marked Second Amended and Restated Articles of Incorporation of WW International, Inc.
    Exhibit 3.4    Marked Amended and Restated Bylaws of WW International, Inc.
    Exhibit 104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

     

    3


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        WW INTERNATIONAL, INC.
    DATED: May 13, 2024     By:  

    /s/ Heather Stark

        Name:   Heather Stark
        Title:   Chief Financial Officer

     

    4

    Get the next $WW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WW

    DatePrice TargetRatingAnalyst
    9/15/2025Market Perform
    CJS Securities
    7/26/2024$6.50 → $1.25Overweight → Equal-Weight
    Morgan Stanley
    1/3/2024$8.00Underweight
    Barclays
    12/20/2023$14.00Buy
    Guggenheim
    9/27/2023$4.00 → $10.00Sell → Hold
    Craig Hallum
    7/26/2023$5.00 → $13.00Equal-Weight → Overweight
    Morgan Stanley
    4/11/2023$3.80 → $13.00Neutral → Buy
    Goldman
    3/8/2023$4.00Hold → Sell
    Craig Hallum
    More analyst ratings

    $WW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney was granted 1,166 shares, increasing direct ownership by 4% to 31,442 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:12 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Bornstein Julie was granted 1,166 shares, increasing direct ownership by 67% to 2,918 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:10 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form 4 filed by Director O'Connor-Brooks Fallon Julia

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    1/6/26 4:01:09 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hawks Carney bought $643,464 worth of shares (29,057 units at $22.14) (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    11/20/25 4:01:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Director Kelly Denis F bought $49,897 worth of shares (64,500 units at $0.77), increasing direct ownership by 80% to 145,421 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:13:04 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer Sistani Sima bought $48,555 worth of shares (65,000 units at $0.75), increasing direct ownership by 32% to 267,410 units (SEC Form 4)

    4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)

    8/8/24 4:06:22 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    SEC Filings

    View All

    SEC Form 8-K filed by WW International Inc.

    8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)

    12/23/25 4:05:21 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by WW International Inc.

    S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)

    11/6/25 4:22:09 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form S-8 POS filed by WW International Inc.

    S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)

    11/6/25 4:20:13 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training. As weight health enters a new era driven by GLP-1 medications and growing awareness of the role lean muscle plays in metabolism, Weight Watchers continues to innovate its science-backed approach to deliver even stronger outcomes for members. Building and preserving muscle plays an important role in long-term health, especially for women in midlife and members using GL

    2/10/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers to Participate in Upcoming Investor Conferences

    NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that the Company will be participating in the following investor conferences in January: January 12-13, 2026: ICR Conference in Orlando, FL. The Company will host meetings with investors throughout the event.January 14, 2026: CJS Securities 26th Annual New Ideas for the New Year. The Company will be participating in a virtual fireside chat at 11:00 a.m. ET. The fireside chat will be accessible via live audio webcast on the Company's corporate website, corporate.ww.com, under Events and Presentations. A r

    1/7/26 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health

    NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced access to Novo Nordisk's newly FDA approved oral formulation of Wegovy® through its integrated GLP-1 platform. The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers' leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support. Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare® Recognized Care Provider based on its demonstr

    1/5/26 8:05:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CJS Securities initiated coverage on WW

    CJS Securities initiated coverage of WW with a rating of Market Perform

    9/15/25 10:08:29 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WW downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously

    7/26/24 7:46:12 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Barclays initiated coverage on WW with a new price target

    Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00

    1/3/24 8:36:04 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Leadership Updates

    Live Leadership Updates

    View All

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman. "Menopause has been a new journey for me—one that's changed how I see a

    9/8/25 8:54:36 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program

    NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman "Menopause has been a new journey for me—one that's changed how I s

    9/8/25 8:50:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Advances International Growth With Strategic Leadership Appointment

    NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers' business outside of the United States, driving international growth and innovation across the Company's global footprint. With more than two decades of experience scaling consumer, e-commerce, and marketplace businesses worldwide, Bethlen will play a pivotal role in strengthening WeightWatchers' leadership in weight health. "Alejandro's international e

    9/3/25 4:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Financials

    Live finance-specific insights

    View All

    WeightWatchers Schedules Third Quarter 2025 Earnings Conference Call

    NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co

    10/30/25 9:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Announces Second Quarter 2025 Results

    Successful completion of strategic reorganization, reducing debt by $1.15 billion.In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a "Successor" period from 6/25/25 to 6/30/25 Combined End of Period Subscribers1 of 3.2 million; Combined End of Period Clinical Subscribers1 of 127 thousand Combined Revenues1 of $189 million, down 6% vs. prior year; Combined Clinical Revenues1 of $31 million, up 55% vs. prior year Predecessor Net Income1 of $1,191 million and Net Margin1 of 673% were impacted by Reorganization items; Successor Net Income1 of $1 million and Net Margin1 of 10%; Predecessor Adjusted EBITDA1,2 of $61 milli

    8/11/25 7:00:37 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence

    NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start Accounting adoption in connection with the emergence from its financial reorganization process on June 24, 2025. The earnings release and call was originally scheduled before the market opened on Tuesday, August 5, 2025. WeightWatchers will now release its second quarter 2025 earnings release before market open on Monday, August 11, 2025, and host a conference call to discuss results the same day at 8:30 a.m. ET. The webcast of the conference c

    8/4/25 5:38:53 PM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $WW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/14/24 6:06:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by WW International Inc.

    SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    11/8/24 10:40:45 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    SEC Form SC 13G filed by WW International Inc.

    SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)

    2/14/24 6:58:51 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary